Cargando…

The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk

The feasibility of a population-based evaluation of screening for prostate cancer in men with a raised familial risk was investigated by studying reasons for non-participation and uptake rates according to postal recruitment and clinic contact. The levels of prostate-specific antigen (PSA) and the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melia, J, Dearnaley, D, Moss, S, Johns, L, Coulson, P, Moynihan, C, Sweetman, J, Parkinson, M C, Eeles, R, Watson, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361168/ https://www.ncbi.nlm.nih.gov/pubmed/16434997 http://dx.doi.org/10.1038/sj.bjc.6602925

Ejemplares similares

Feasibility of familial PSA screening: psychosocial issues and screening adherence
por: Sweetman, J, et al.
Publicado: (2006)

Do men with prostate or colorectal cancer seek different information and support from women with cancer?
por: Boudioni, M, et al.
Publicado: (2001)

A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival
por: Parker, C, et al.
Publicado: (2006)

Urological referral of asymptomatic men in general practice in England
por: Melia, J, et al.
Publicado: (2008)

The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer
por: Castro, Elena, et al.
Publicado: (2016)

The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels.
por: Cote, R. J., et al.
Publicado: (1998)

Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group.
por: Dunsmuir, W. D., et al.
Publicado: (1998)

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
por: Mikropoulos, Christos, et al.
Publicado: (2018)

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
por: Mikropoulos, Christos, et al.
Publicado: (2018)

Raising cut-off value of prostate specific antigen (PSA) for biopsy in symptomatic men in India to reduce unnecessary biopsy
por: Agnihotri, Shalini, et al.
Publicado: (2014)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
por: Abotsi, Ebenezer, et al.
Publicado: (2022)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen level
por: Coltman, C A
Publicado: (1999)

Men with a susceptibility to prostate cancer and the role of genetic based screening
por: Eeles, Rosalind, et al.
Publicado: (2018)

Construction of tissue microarrays from prostate needle biopsy specimens
por: Jhavar, S, et al.
Publicado: (2005)

Ethnic differences in prostate-specific antigen levels in men without prostate cancer: a systematic review
por: Barlow, Melissa, et al.
Publicado: (2022)

Updates in Prostate Cancer Research and Screening in Men at Genetically Higher Risk
por: Bancroft, Elizabeth K., et al.
Publicado: (2021)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
por: Putra, Ida Bagus O.W., et al.
Publicado: (2016)

No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group.
por: Edwards, S. M., et al.
Publicado: (1997)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Histopathology, pharmacotherapy, and predictors of prostatic malignancy in elderly male patients with raised prostate-specific antigen levels – A prospective study
por: Mathaiyan, Dhinesh Kumar, et al.
Publicado: (2020)

Prostate-Specific Antigen (PSA) and Prostate Volume: Better Predictor of Prostate Cancer for Bosnian and Herzegovina Men
por: Coric, Jozo, et al.
Publicado: (2015)

Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing
por: Jackson, Sherena D, et al.
Publicado: (2022)

How can we recruit more men of African or African-Caribbean ancestry into our research? Co-creating a video to raise awareness of prostate cancer risk and the PROFILE study
por: Hainsworth, Emma, et al.
Publicado: (2022)

Raised prostate-specific antigen alone may not be a true predictor in high-risk prostate cancer: A retrospective cohort analysis
por: Garg, Harshit, et al.
Publicado: (2022)

Natural History of Untreated Prostate Specific Antigen Radiorecurrent Prostate Cancer in Men with Favorable Prognostic Indicators
por: Martin, Neil E., et al.
Publicado: (2014)

Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review
por: Vernooij, Robin W M, et al.
Publicado: (2018)

Is targeted biopsy really needed when performing systematic prostate biopsy to raise the detection rate for prostate cancer in patients with prostate-specific antigen ≤10 ng/mL?
por: Park, Jee Soo, et al.
Publicado: (2019)

Transition Zone Prostate Specific Antigen Density Improves Prostate Cancer Detection in Iranian Men
por: Nowroozi, Mohammadreza, et al.
Publicado: (2015)

Feasibility of Presurgical Exercise in Men With Prostate Cancer Undergoing Prostatectomy
por: Singh, Favil, et al.
Publicado: (2016)

Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer
por: Moynihan, C., et al.
Publicado: (2017)

Prostate‐specific antigen testing among young men: an opportunity to improve value
por: Lange, Suzanne M., et al.
Publicado: (2021)

Blood and urine biomarkers in prostate cancer: Are we ready for reflex testing in men with an elevated prostate-specific antigen?
por: Chang, Edward K., et al.
Publicado: (2021)

The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria
por: Agalliu, Ilir, et al.
Publicado: (2015)

Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels
por: Bang, Seokhwan, et al.
Publicado: (2021)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
por: Rosario, Derek J, et al.
Publicado: (2012)

Initial Longitudinal Outcomes of Risk-Stratified Men in Their Forties Screened for Prostate Cancer Following Implementation of a Baseline Prostate-Specific Antigen
por: Michael, Zoe D., et al.
Publicado: (2023)

ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI
por: Marsden, Teresa, et al.
Publicado: (2021)

Prostate-Specific Antigen Concentrations in Response to Testosterone Treatment of Severely Hypogonadal Men
por: Sachdev, Saachi, et al.
Publicado: (2020)

Relationships between Prostate-Specific Antigen, Prostate Volume, and Components of Metabolic Syndrome in Healthy Korean Men
por: Byun, Hyun Keun, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_40829cpld8alc1b2lih6ckv8q8